Fortress Biotech, Inc. (FBIO) KPIs and segments
Close on Nov 13, 2026Market cap $69.14MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Fortress Biotech's business
Fortress Biotech's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Journey($M) | 18.5 | 16.0 | 16.1 | 17.6 | 15.0 | 13.1 | 13.6 | 14.6 | 14.9 | 13.0 | |||
Fortress($M) | 0.21 | 0.08 | |||||||||||
Avenue($M) | 0 | 0 | 1.40 | ||||||||||
Earlier reporting (last reported 2024)3 | |||||||||||||
Emrosi($M) | 8.07 | 6.25 | 5.00 | 4.88 | 2.80 | 2.07 | |||||||
Qbrexza($M) | 5.11 | 5.03 | 5.54 | 7.36 | 6.95 | 5.16 | 5.68 | 7.58 | 6.84 | 5.02 | 7.37 | 5.87 | |
Accutane($M) | 3.36 | 3.31 | 3.06 | 2.77 | 3.40 | 3.66 | 3.87 | 4.00 | 5.72 | 5.82 | 5.06 | 4.88 | |
Vyne acquisition products (Amzeeq & Zilxi)($M) | 1.31 | 2.10 | |||||||||||
Foam franchise products (Amzeeq & Zilxi)($M) | 0.94 | 1.05 | 1.14 | 1.53 | |||||||||
Amzeeq($M) | 0.88 | 1.10 | 1.51 | 1.54 | 1.21 | 0.76 | 1.30 | 2.34 | |||||
Zilxi($M) | 0.26 | 0.43 | 0.44 | 0.56 | 0.37 | 0.27 | 0.40 | 0.68 | |||||
Other / legacy product revenue($M) | 0.23 | 0.28 | 0.58 | 0.70 | 0.74 | 0.73 | 1.12 | 0.95 | 0.73 | 1.17 | 1.13 | 1.52 | |
Eurax($M) | 0.12 | ||||||||||||
Royalty revenue($M) | 0.08 | 0 | 0 | ||||||||||
Earlier reporting (last reported 2024)4 | |||||||||||||
Journey($M) | 0.46 | -1.49 | -0.44 | -1.53 | -2.94 | -3.32 | 2.23 | -2.89 | -2.93 | -10.1 | |||
Checkpoint Merger($M) | 0 | 0 | -26.9 | -11.1 | -28.8 | -9.72 | -6.67 | -10.9 | |||||
Avenue($M) | -0.71 | -0.71 | -0.75 | -0.72 | 0.30 | -1.91 | -1.60 | -3.16 | -2.82 | -3.71 | |||
Mustang($M) | -1.17 | -1.06 | -0.67 | -0.62 | -0.89 | -0.25 | -1.02 | -1.46 | -8.54 | -5.23 | |||
Fortress($M) | -8.59 | -4.48 | -2.92 | -3.93 | -6.06 | -5.69 | 5.37 | -4.86 | -6.83 | -6.59 | |||
Fortress($M) | 2.98 | 146 | -3.70 | 12.3 | 3.85 | -10.0 | |||||||
Checkpoint Merger($M) | 0 | -28.9 | -9.73 | ||||||||||
Journey($M) | -0.30 | -2.23 | -1.25 | -2.32 | 1.58 | -2.39 | |||||||
Avenue($M) | -0.69 | -0.70 | -0.73 | -0.69 | -1.56 | -3.09 | |||||||
Mustang($M) | -1.07 | -0.96 | -0.54 | -0.47 | -0.95 | -1.41 | |||||||
Fortress($M) | 201 | 246 | 70.4 | 73.1 | 61.5 | 40.4 | 44.5 | 48.0 | 61.3 | 68.2 | 65.7 | ||
Journey($M) | 98.4 | 91.5 | 94.6 | 85.2 | 81.2 | 85.0 | 80.2 | 64.0 | 65.2 | 66.6 | 76.8 | ||
Mustang($M) | 15.6 | 16.6 | 17.6 | 19.4 | 13.0 | 14.9 | 9.31 | 7.19 | 8.52 | 14.6 | 17.7 | ||
Avenue($M) | 1.98 | 2.47 | 2.93 | 3.73 | 4.16 | 3.59 | 2.67 | 2.63 | 4.99 | 3.31 | 1.85 | ||
Earlier reporting (last reported 2025)3 | |||||||||||||
Earlier reporting (last reported 2026)3 | |||||||||||||
13 metrics have no data in the last 12 quarters — .
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-08-13.
See a number that looks wrong?